PI
MDCO

Placemark Investments’s Medicines Co MDCO Stock Holding History

Placemark Investments’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,199
Closed -$201K – 1693
2013
Q4 		$201K Buy
+5,199
New +$186K ﹤0.01% 1527

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Placemark Investments's MDCO Position: Q1 2014 in Review

Placemark Investments sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 5,199 shares — an estimated $201K sold.

Placemark Investments first reported a position in MDCO in Q4 2013 and held it in 1 quarter. The position peaked at $201K in Q4 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

  • Placemark Investments reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
  • Placemark Investments sold 5,199 Medicines Co shares in Q1 2014, an estimated $201K.
  • Placemark Investments first reported a position in Medicines Co in Q4 2013 and held it in 1 quarter.
  • Placemark Investments's Medicines Co position peaked at $201K in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Placemark Investments's 13F filing for Q1 2014, filed 9 May 2014.